Healthcare executives who have both scientific expertise and strong commercial awareness have never been at a higher premium. Driven by a wave of mergers and acquisitions, multinational pharmaceutical giants are keener than ever to be seen as an employer of choice.

At the same time, biotechnology start-ups want to attract the kind of executive credentials that will satisfy their investors and grow their business from a strong foundation.